Bron:

| 64593 x gelezen

Source: Daily Mail

Date: 16th May 2006

A drug used to treat herpes infections has produced a dramatic improvement in patients severely affected by ME, or fatigue syndrome.

Sufferers who for years had been unable to leave their homes now report being able to resume normal life.

This is a remarkable result for a treatment for this complex and controversial disorder that is thought to affect as many as 240,000 people in Britain and for which there is no cure.

The results, reported at a scientific conference earlier this month by Professor Jose Montoya of Stanford University in California, involved 12 patients who had been given the powerful drug valganciclovir, which targets the human herpes virus (HHV-6). Nine of the patients experienced a great improvement.

Lees het volledige artikel op MailOnline

Geef een reactie

Zijbalk

Volg ons
Datum/Tijd Evenement
29/10/2026
19:30 - 22:00
Masterclasses PAIS voor artsen
Recente Links
ma
di
wo
do
vr
za
zo
m
d
w
d
v
z
z
1
2
3
4
5
6
7
8
9
10
12
13
14
16
17
18
19
20
21
22
23
25
26
27
28
29
30
1
2
3
4
Screening Unrest in Antwerpen
11/01/2018    
20:00
Extra voorstelling te Antwerpen op donderdag 11 januari 2018 (20u)  Locatie: Auditorium Permeke, De Coninckplein 25 – 2060 Antwerpen Inkom 5€ (er zijn eveneens 100 plaatsen beschikbaar) Reserveren kan door te mailen [...]
Screening Unrest in Rotterdam
15/01/2018    
19:00
Unrest continues its tour around the Netherlands. We will be at the Kino Rotterdam on Monday evening, 15 January 2018. Please join us in thanking [...]
Screening Unrest in Leiden
24/01/2018    
19:00
Did you miss the previous Unrest screening in Leiden? Here's your second chance! Come join us at the Kijkhuis on Wednesday, 24 January at 19:00. [...]
Screening Unrest in Nijmegen
31/01/2018    
19:00
Op woensdag 31 januari a.s. in Filmhuis O42 in NijmegenDe film begint om 19:00 uur. Erna zal een korte vraag- en antwoordsessie worden gehouden.Er is [...]
Evenement op 11/01/2018
Evenement op 15/01/2018
Evenement op 24/01/2018
Evenement op 31/01/2018